Sclerostin: a novel target for intervention in the treatment of osteoporosis.

Discovery medicine

Volumn 12, Issue 65, 2011, Pages 263-273

  Lewiecki, E Michael ^a  

^a NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MONOCLONAL ANTIBODY; SOST PROTEIN, HUMAN;

GENETIC MARKER; GENETICS; HUMAN; METABOLISM; MUTATION; OSTEOPOROSIS; REVIEW;

ANTIBODIES, MONOCLONAL; BONE MORPHOGENETIC PROTEINS; GENETIC MARKERS; HUMANS; MUTATION; OSTEOPOROSIS;

EID: 84859631972     PISSN: None     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Review

References (0)